Mario Saltarelli

Mario Saltarelli

Company: Gaba Therapeutics

Job title: CEO/Chief Medical Officer


Uncovering the Link Between Endogenous Brain Steroids & Inflammasomes to Uncover Novel Mechanisms of Inhibiting the Inflammasome Pathway 3:30 pm

GRX-917, through inducing endogenous neurosteroid production and inhibiting NLRP3 inflammation, presents a novel approach with potential benefits across neuropsychiatric, neurological, and autoimmune disorders Exploring GRX-917’s improved pharmacokinetic profile derived from deuterium stabilization while maintaining efficacy and safety akin to its predecessor, EtifoxineRead more

day: Day 1

Back to Basic Biology: Uncovering the Role of Inflammasomes in Health & Disease for Enhanced Understanding & Improved Therapeutic Targeting 10:00 am

This interactive discussion led session gathers thought leaders, expert researchers, and industry leaders to dive into the fundamentals of inflammasome biology and its implications for disease mechanisms to uncover therapeutic strategies. Join an interdisciplinary dialogue to ask your burning questions to a niche audience of inflammasome experts to tackle these scientific challenges head-on. Hear the…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.